everal weeks ago, for example, the Food and Drug Administration released a fact sheet on a monoclonal antibody called sotrovimab. Sotrovimab is, at this point, the only monoclonal antibody treatment that has proven effective against the latest variant of the coronavirus. The FDA provided guidance for physicians in all 50 states, telling them how to determine which patients should get this critical treatment. Physicians, the FDA explained, should consider quote race and ethnicity as they administer treatments, and so physicians are doing that across the country.

In Utah, COVID patients are triaged by a scoring system that determines whether they qualify for these potentially life-saving antibody treatments. If you look at the scoring system, you'll notice that race often counts more than physical health. The state of Utah, for example, gives two points to anyone simply for not being White. You win if you're not White. If you have congestive heart failure at the same time, you get one point. So if you're a White, congestive heart failure patient, that's not enough for you.